Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-10 of 10 for your search:
Drug:
hydroxychloroquine
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase I/II Study of Hydroxychloroquine, Radiotherapy, and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Phase:
Phase II, Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
ABTC-0603
, NABTT-0603, 0603, NCT00486603
2.
Phase I/II Study of Hydroxychloroquine and Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma
Phase:
Phase II, Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UPCC-01407
, UPCC 01407, UPCC-IRB-806149, NCT00568880
3.
Phase I/II Study of Hydroxychloroquine in Combination With Carboplatin, Paclitaxel, and Bevacizumab in Patients With Recurrent Advanced Non-Small Cell Lung Cancer
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CINJ-030801
, 030801, NCT00728845
4.
Phase I/II Study of Ixabepilone and Hydroxychloroquine in Patients With Taxane- and Anthracycline-Resistant Metastatic Breast Cancer
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CINJ-040804
, 040804, CINJ-0220080205, NCT00765765
5.
Hydroxychloroquine and Gefitinib to Treat Lung Cancer
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
21 and over
Sponsor:
Other
Protocol IDs:
NS 01/03/08
, NCT00809237
6.
Phase II Study of Hydroxychloroquine in Patients With Hormone-Dependent Prostate-Specific Antigen (PSA) Progression After Local Therapy for Prostate Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CINJ-080803
, 080803, NCT00726596
7.
Hydroxychloroquine in Untreated B-CLL Patients
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Over 18
Sponsor:
Other
Protocol IDs:
08-088
, NCT00771056
8.
Phase II Study of Docetaxel and Hydroxychloroquine in Patients With Metastatic Hormone-Refractory Chemotherapy-Naive Prostate Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Over 18
Sponsor:
NCI
Protocol IDs:
CINJ-080805
, 080805, 0220080244, NCT00786682
9.
Phase I Study of Hydroxychloroquine and Temozolomide in Patients With Metastatic or Unresectable Solid Tumors
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UPCC-12907
, UPCC 12907, NCT00714181
10.
Phase I Study of Sunitinib Malate and Hydroxychloroquine in Patients With Advanced Solid Tumors Refractory to Standard Chemotherapy
Phase:
Phase I
Type:
Treatment
Status:
Approved-not yet active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CINJ-050801
, 050801, 0220080281, NCT00813423
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute